NO972449L - Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav - Google Patents
Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse deravInfo
- Publication number
- NO972449L NO972449L NO972449A NO972449A NO972449L NO 972449 L NO972449 L NO 972449L NO 972449 A NO972449 A NO 972449A NO 972449 A NO972449 A NO 972449A NO 972449 L NO972449 L NO 972449L
- Authority
- NO
- Norway
- Prior art keywords
- arylcarbonyloxymethyl
- thiadiazolidin
- substituted
- preparations
- dioxide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/349,341 US5556909A (en) | 1994-12-02 | 1994-12-02 | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof |
PCT/US1995/015504 WO1996016951A1 (en) | 1994-12-02 | 1995-11-30 | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO972449D0 NO972449D0 (no) | 1997-05-29 |
NO972449L true NO972449L (no) | 1997-07-22 |
Family
ID=23371974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972449A NO972449L (no) | 1994-12-02 | 1997-05-29 | Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav |
Country Status (12)
Country | Link |
---|---|
US (1) | US5556909A (fi) |
EP (1) | EP0801648A4 (fi) |
JP (1) | JPH10509979A (fi) |
CN (1) | CN1173175A (fi) |
AU (1) | AU703622B2 (fi) |
CA (1) | CA2205837A1 (fi) |
FI (1) | FI972306A0 (fi) |
HU (1) | HUT77364A (fi) |
MX (1) | MX9704034A (fi) |
NO (1) | NO972449L (fi) |
NZ (1) | NZ298266A (fi) |
WO (1) | WO1996016951A1 (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420401B1 (en) * | 1997-08-22 | 2002-07-16 | Wichita State University | 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives |
DOP2000000107A (es) | 1999-12-01 | 2002-09-16 | Agouron Pharmaceutical Inc | Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas |
US7405234B2 (en) * | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
GB0225986D0 (en) * | 2002-11-07 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
EP1567487A4 (en) * | 2002-11-15 | 2005-11-16 | Bristol Myers Squibb Co | OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION |
CA2511818A1 (en) * | 2002-12-30 | 2004-07-29 | Jeffrey O. Saunders | Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
US7256208B2 (en) * | 2003-11-13 | 2007-08-14 | Bristol-Myers Squibb Company | Monocyclic N-Aryl hydantoin modulators of androgen receptor function |
US7820702B2 (en) * | 2004-02-04 | 2010-10-26 | Bristol-Myers Squibb Company | Sulfonylpyrrolidine modulators of androgen receptor function and method |
US20050182105A1 (en) * | 2004-02-04 | 2005-08-18 | Nirschl Alexandra A. | Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function |
US7696241B2 (en) * | 2004-03-04 | 2010-04-13 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
US7388027B2 (en) * | 2004-03-04 | 2008-06-17 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
US7625923B2 (en) * | 2004-03-04 | 2009-12-01 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
WO2020219720A1 (en) * | 2019-04-23 | 2020-10-29 | The Cleveland Clinic Foundation | Allosteric activators of the alpha1a -adrenergic receptor |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236917A (en) * | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
US5128339A (en) * | 1990-11-01 | 1992-07-07 | Sterling Winthrop Inc. | Proteolytic enzyme inhibition method |
US5306818A (en) * | 1990-11-01 | 1994-04-26 | Sterling Winthrop Inc. | Tetrahydro 2-saccharinylmerthyl aryl carboxylates |
DE4141218A1 (de) * | 1991-12-13 | 1993-06-17 | Luitpold Werk Chem Pharm | Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel |
US5378720A (en) * | 1991-12-19 | 1995-01-03 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
US5550139A (en) * | 1994-01-03 | 1996-08-27 | The Wichita State University | Serine protease inhibitors |
-
1994
- 1994-12-02 US US08/349,341 patent/US5556909A/en not_active Expired - Fee Related
-
1995
- 1995-11-30 NZ NZ298266A patent/NZ298266A/en unknown
- 1995-11-30 CA CA002205837A patent/CA2205837A1/en not_active Abandoned
- 1995-11-30 JP JP8519027A patent/JPH10509979A/ja active Pending
- 1995-11-30 MX MX9704034A patent/MX9704034A/es unknown
- 1995-11-30 CN CN95197428A patent/CN1173175A/zh active Pending
- 1995-11-30 HU HU9701852A patent/HUT77364A/hu unknown
- 1995-11-30 AU AU43710/96A patent/AU703622B2/en not_active Ceased
- 1995-11-30 EP EP95942505A patent/EP0801648A4/en not_active Withdrawn
- 1995-11-30 WO PCT/US1995/015504 patent/WO1996016951A1/en not_active Application Discontinuation
-
1997
- 1997-05-29 NO NO972449A patent/NO972449L/no unknown
- 1997-05-30 FI FI972306A patent/FI972306A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
FI972306A (fi) | 1997-05-30 |
AU703622B2 (en) | 1999-03-25 |
JPH10509979A (ja) | 1998-09-29 |
MX9704034A (es) | 1998-02-28 |
US5556909A (en) | 1996-09-17 |
CA2205837A1 (en) | 1996-06-06 |
FI972306A0 (fi) | 1997-05-30 |
EP0801648A4 (en) | 1998-01-28 |
NZ298266A (en) | 1998-11-25 |
WO1996016951A1 (en) | 1996-06-06 |
HUT77364A (hu) | 1998-03-30 |
NO972449D0 (no) | 1997-05-29 |
AU4371096A (en) | 1996-06-19 |
CN1173175A (zh) | 1998-02-11 |
EP0801648A1 (en) | 1997-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
NO954342L (no) | Erytropoietinanalogblandinger, samt fremgangsmåter ved fremstilling derav | |
NO973479L (no) | Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme | |
NO965298L (no) | Ny krystallmodifikasjon av CDCH, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende denne | |
DE3478810D1 (en) | Benzazocinone and benzazoninone derivatives, process for their preparation, pharmaceutical preparations containing these compounds, and their therapeutical use | |
IL94278A0 (en) | 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them | |
NO972449L (no) | Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav | |
NO991637D0 (no) | Aminotiazolderivater, fremgangsmÕte ved fremstilling derav og farmas°ytiske blandinger inneholdende disse | |
TW221056B (fi) | ||
AU3192084A (en) | Pharmaceutical compositions of benzothiophene derivatives | |
ITMI931649A1 (it) | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico | |
KR950700310A (ko) | 헤테로트리사이클릭 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물(heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them) | |
MA22495A1 (fr) | Derives d'amidinophenylalanine, procede pour leur preparation et leur utilisation | |
NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
NO972450L (no) | Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav | |
NO972435L (no) | 2-(2,3,5,6-tetrafluor-4-pyridyl)-1,2,5-tradiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
DE3879709T2 (de) | Platin-arzneimittel. | |
IT1269740B (it) | Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione | |
DK130293D0 (da) | Benzox(thi)azine derivatives, pharmaceutical compositions thereof, and method of treating therewith | |
DK53593D0 (da) | Oe1,2,4aatriazolooe4,3-aaaquinoxalinonforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse |